Skip to main content
Livermore
Livermore
ZHEN

Lipe & Dalton

SEC CIK
0001570396
Latest filing
Jul 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Lipe & Dalton, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
1,580
Value
$143.0K
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of ABT by Lipe & Dalton, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,580$143.0K0.1%+160+11.3%AddedHolders
Q1 20261,420$146.0K0.1%+400+39.2%AddedHolders
Q4 20251,020$128.0K0.1%−410−28.7%ReducedHolders
Q3 20251,430$192.0K0.1%−300−17.3%ReducedHolders
Q2 20251,730$235.0K0.1%00.0%UnchangedHolders
Q1 20251,730$229.0K0.1%+1,730NewHolders
Q4 20240$00.0%−1,980−100.0%Sold outHolders
Q3 20241,980$226.0K0.1%00.0%UnchangedHolders
Q2 20241,980$206.0K0.1%−34−1.7%ReducedHolders
Q1 20242,014$229.0K0.1%00.0%UnchangedHolders
Q4 20232,014$222.0K0.1%00.0%UnchangedHolders
Q3 20232,014$195.0K0.1%00.0%UnchangedHolders
Q2 20232,014$220.0K0.1%00.0%UnchangedHolders
Q1 20232,014$204.0K0.1%00.0%UnchangedHolders
Q4 20222,014$221.0K0.1%−300−13.0%ReducedHolders
Q3 20222,314$224.0K0.1%00.0%UnchangedHolders
Q2 20222,314$251.0K0.1%00.0%UnchangedHolders
Q1 20222,314$274.0K0.1%00.0%UnchangedHolders
Q4 20212,314$326.0K0.2%+34+1.5%AddedHolders
Q3 20212,280$269.0K0.1%−150−6.2%ReducedHolders
Q2 20212,430$282.0K0.1%00.0%UnchangedHolders
Q1 20212,430$291.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.